AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML

This publication has 208 references indexed in Scilit:

• Polyomavirus Enhancer-binding Protein 2/Core Binding Factor/Acute Myeloid Leukemia Factors Contribute to the Cell Type-specific Activity of the CD11a Integrin Gene Promoter
  Published by Elsevier ,2000
• Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31
  Oncogene, 2000
• Crystal Structure of the Nuclear Matrix Targeting Signal of the Transcription Factor Acute Myelogenous Leukemia-1/Polyoma Enhancer-binding Protein 2αB/Core Binding Factor α2
  Journal of Biological Chemistry, 1999
• Identification of the Region of mi Transcription Factor Which Is Responsible for the Synergy with PEBP2/CBF
  Biochemical and Biophysical Research Communications, 1999
• Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A
  Oncogene, 1999
• TLE, the Human Homolog of Groucho, Interacts with AML1 and Acts as a Repressor of AML1-Induced Transactivation
  Biochemical and Biophysical Research Communications, 1998
• Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials
  British Journal of Haematology, 1997
• Ribozymes Cleave the AML1/MTG8 Fusion Transcript and Inhibit Proliferation of Leukemic Cells with t (8;21)
  Biochemical and Biophysical Research Communications, 1995
• Increased Expression of AML1 during Retinoic-Acid-Induced Differentiation of U937 Cells
  Biochemical and Biophysical Research Communications, 1995
• Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells
  Cancer Genetics and Cytogenetics, 1992